Fundz

MB Therapeutics secured €2 million in seed funding led by prominent investors to develop a pharmaceutical facility for 3D printing personalized medicines.

PRIVATEFeb 25, 2025

Amount Raised

€2 Million

Round Type

Seed

MontpellierManufacturingBiotechnology3D Printing

Investors

Banque Publique D'investissementSébastien GalliceAngels SantéCalyseedBeprep

Description

MB Therapeutics, based in Montpellier, has raised €2 million in seed funding to create a facility that will enable pharmacies to produce personalized medicines on-site using 3D printing technology. This funding will also support the launch of three high-demand medicines and prepare the company for a Series A funding round in 2026.

Quick answer

MB Therapeutics raised €2 Million in a Seed round, dated February 25, 2025. Investors: Banque Publique D'investissement, Sébastien Gallice, Angels Santé, Calyseed and Beprep. MB Therapeutics is based in Montpellier, Occitania, France.

How much did MB Therapeutics raise?
MB Therapeutics raised €2 Million in a Seed round on February 25, 2025.
Who invested in MB Therapeutics?
Banque Publique D'investissement, Sébastien Gallice, Angels Santé, Calyseed and Beprep are named as investors in this round.
What does MB Therapeutics do?
MB Therapeutics is a Montpellier-based startup specializing in pharmaceutical 3D printing with over 8 years of expertise.
Where is MB Therapeutics based and how big is it?
MB Therapeutics is based in Montpellier, Occitania, France. Fundz records about 8 employees.
Who are the decision-makers at MB Therapeutics?
Fundz holds 1 contact at MB Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in 3D Printing and Manufacturing around the same time

Companies in the same sectors as MB Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Lexington Medical raised $38M on April 11, 2025.
  • Neuranics raised $8M (Funding Round) on April 9, 2025.
  • FaradaIC Sensors raised $4.9M (Seed) on April 7, 2025.
  • Ecoat raised $23M (Funding Round) on April 3, 2025.
  • Bloom Biorenewables raised $14M (Series A) on April 3, 2025.
  • CMR Surgical raised $200M on April 2, 2025.

Who to call at MB Therapeutics, and when

A new round usually means MB Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MB Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MB Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MB Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MB Therapeutics

Location

Montpellier, Occitania, France

About

MB Therapeutics is a Montpellier-based startup specializing in pharmaceutical 3D printing with over 8 years of expertise. The company is focused on developing solutions for personalized medicine production in pharmacies, thereby enhancing precision and addressing growing demands for individualized treatments. MB Therapeutics aims to reduce drug shortages and pharmaceutical waste by enabling on-site production of customized medicines. Their innovative approach involves providing pharmacies with advanced 3D printing technology and pre-filled cartridges.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MB Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MB Therapeutics's next move

See what Strategic adds

MB Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.